Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI)	Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, bronchial disorder, bronchiectasis, cystic fibrosis, disease, hereditary disease, hidradenitis, hidradenitis suppurativa, lung disorder, pancreas disorder, respiratory system disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder	Recruiting	Not stated	2026-09-21		NCT06368388

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AZ Sint-Jan AV	28
Clinique Saint Pierre Ottignies	2
Cliniques universitaires Saint-Luc- Université Catholique de Louvain	66
KU Leuven	110
Queen Astrid Military Hospital	1
Sciensano	6
Universitair Ziekenhuis Brussel	114
Universitaire Ziekenhuizen KU Leuven	262
University Ghent	108
University Hospital, Antwerp	108

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospitals Leuven	Leuven	Belgium	32